Osteolytic lesions in patients with relapse of diffuse large B-cell lymphoma treated with lenalidomide.
Department of Hematology and Oncology, Georg-August-University Goettingen, Robert-Koch-Strasse 40, 37075, Goettingen, Germany, nikolai.schuelper@med.uni-goettingen.de.
Nikolai
N
Schuelper
Antonius
A
Flohr
Lorenz
L
Trümper
Gerald G
GG
Wulf
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D016403:Lymphoma, Large B-Cell, Diffuse / Q000000981:diagnostic imaging* / Q000188:drug therapy; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging* / Q000188:drug therapy; D010014:Osteolysis / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D011859:Radiography; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D013792:Thalidomide; D000077269:Lenalidomide